Results 231 to 240 of about 100,944 (279)

Role of Interleukin-6 in Atherothrombosis and Myocardial Infarction. [PDF]

Curr Atheroscler Rep
Huse C, Gregersen I, Holme FA, Ueland T, Skjelland M, Aamodt AH, Dahl TB, Aukrust P, Halvorsen B.   +8 more
europepmc   +1 more source

Talquetamab: Mechanism of Action, Clinical, and Translational Science

Clinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT Talquetamab is a first‐in‐class, T‐cell–redirecting bispecific antibody targeting GPRC5D, a novel antigen highly expressed on malignant plasma cells with limited expression in normal tissues. Despite advances in treatment, multiple myeloma (MM) remains incurable, and talquetamab offers a promising therapeutic option for patients with relapsed ...
Yibo Wang, Jue Gong, Nicholas Au, Jie Zhou, Dongfen Yuan, Jaszianne Tolbert, Guoqiang Zhang, Deeksha Vishwamitra, Jenny Zhang, Nahor Haddish‐Berhane, Indrajeet Singh   +10 more
wiley   +1 more source

Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric study. [PDF]

Sci Rep
Lefèvre C, Funck-Brentano T, Cachanado M, Plocque A, Youinou M, Fels A, Pène F, Savale L, Montani D, Voisin O, Bintein F, Wildenberg L, Philippe A, Legriel S, Roche N, Burgel PR, Tran M, Noël N, Baillard C, Duranteau J, Chatellier G, Philippart F.   +21 more
europepmc   +1 more source

Microbiome‐Based Modeling of CAR‐T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing

European Journal of Haematology, Volume 116, Issue 5, Page 646-662, May 2026.
ABSTRACT The interplay between the commensal microbiota and the mammalian immune system may influence the outcomes of T cell‐driven cancer immunotherapies. However, clinical studies supporting microbiota‐based interventions in chimeric antigen receptor T‐cell (CAR‐T) therapy remain scarce.
Rafael Hernani, Eliseo Albert, Carlos Hernani‐Morales, Sheila Zúñiga, Ana Benzaquén, Laura González‐Castillo, Ester Colomer, Júlia Morell, José Francisco Català‐Senent, José Luis Piñana, Estela Giménez, Ariadna Pérez, Juan Carlos Hernández‐Boluda, Ignacio Arroyo, Marcos Rivada, Teresa Barber, Teresa Alemany, Enric Santacatalina, Pilar Rentero‐Garrido, María José Terol, Rafael Díaz, David Navarro, Carlos Solano   +22 more
wiley   +1 more source

IL-1R/IL-6R blockade for null NLRP12 variant-carrying Takayasu arteritis. [PDF]

Rheumatology (Oxford)
Argyropoulou OD, Marinakis NM, Charalampopoulos G, Tilemis FN, Liasis N, Manoussakis MN.   +5 more
europepmc   +1 more source

Systemic Molecularly Targeted Therapies for Neoadjuvant and Salvage Craniopharyngioma: A Contemporary Narrative Review. [PDF]

Biomedicines
Neubecker JJ, Griepp DW, Turnbull JP, Caskey J, Desai S, Mansour A, Ahmed R, Beggs A, Griepp ATK, Heitkotter H, Claus CF, Richards BF, Kelkar PS.   +12 more
europepmc   +1 more source

Long-term follow-up of linear scleroderma en coup de sabre in children with central nervous system involvement. [PDF]

Front Immunol
Chang X, Ren L, Wu Y, Zhang Y, Wei C, Zhang Q, Zhang M, Zhao C, Bao X.   +8 more
europepmc   +1 more source

Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Kang H, Wu X, Xu H, Huang Y, Zhang M.
europepmc   +1 more source